Under the agreement Dr. Reddy's sold its US and select territory rights for ZEMBRACE® SYMTOUCH®(sumatriptan injection) 3 mg and TOSYMRA™ (sumatriptan nasal spray) 10 mg, which werecommercialized through its wholly owned subsidiary, Promius Pharma, LLC
Powered by Capital Market - Live News